Image For Activity Cover
Virtual Visiting Professorship Series: Quality & Outcomes in HPB Cancer Surgery - Module 3: Equitable and Equal Quality of Care in HPB Cancer Surgery (2024)
Activity Description/ Purpose

Join the members of our Hepato-Pancreato-Biliary (HPB) Disease Site Work Group for a discussion on crucial aspects of quality care in HPB cancer surgery. Surgeons will share insights on tools and methods to enhance patient care, covering topics like quality indicators, standard requirements, operative standards, and addressing disparities.

Module 3 will review data and solutions for inequalities and inequities in receipt of guideline-concordant care and clinical trials enrolment across patient populations with vulnerabilities, as well as for disparities that may arise with centralization of surgical care. 


The faculty for this activity are listed below:

Julie Hallet, MD, M.Sc., FRSC (Moderator)
Sunnybrook Health Sciences Centre

Patricio Polanco, MD (Moderator)
UT Southwestern

Teviah Sachs, MD, MPH (Presenter)
Boston University School of Medicine 

Ugwuji Maduekwe, MD, MMSc, MPH, FACS, FSSO (Presenter)
Medical College of Wisconsin 

Zhi Ven Fong, MD, MPH, DrPH (Presenter)

Mayo Clinic Arizona 

1 minute: Welcome & Introductions: Drs. Julie Hallet and Patricio Polanco

12 minutes: Disparities in receipt of guideline concordant care: Dr. Teviah Sachs

12 minutes: Disparities in receipt of cutting edge care and clinical trials opportunities: Dr. Ugwuji Maduekwe

12 minutes: Disparities in accessing centralized care centres: Dr. Zhi Fong

22 minutes: Discussion with speakers & participants: Faculty

1 minute: Closing: Drs. Julie Hallet and Patrico Polanco
Target Audience

This activity is intended for all surgeons and other health care professionals who are involved in the treatment of patients with HPB cancer.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Explore current data on inequalities and inequities in access to, delivery of and outcomes of HPB cancer surgery across diverse patient populations.
  • Provide a platform for interactive discussions to exchange best practices and address challenges faced by surgical oncologists across different practices.  

The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The Society of Surgical Oncology designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Earning Credit and Method of Participation

This activity consists of educational content and an evaluation. Learners must view the activity content and complete the post-activity evaluation. A certificate of credit or participation will be available upon successful submission of the post-activity evaluation.

Estimated Time to Complete Activity

The estimated time to complete this entire activity is 1 hour.

Release Date

           April 11, 2024

CME Expiration Date

           April 11, 2025


As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.

All identified conflicts of interests have been mitigated.


Julie Hallet, MD, M.Sc., FRSC (Moderator/Presenter) has disclosed the following financial relationships Ipsen, Novartis, Medtronic.

Patricio Polanco, MD (Moderator/Presenter) has disclosed the following financial relationships - Palisade Bio, IOTA Bio Inc.

Teviah Sachs, MD, MPH (Presenter) has disclosed no financial relationships.

Ugwuji Maduekwe, MD, MMSc, MPH, FACS, FSSO (Presenter) has disclosed the following financial relationships - The Cigna Group - SBAS/Cigna Academic Research.

Zhi Ven Fong, MD, MPH, DrPH (Presenter) has disclosed no financial relationships.


Planners, Reviewers, and Staff
Timothy Fitzgerald, CME Committe Chair and Reviewer has disclosed no financial relationships.

Carlos HF Chan, MD, PhD, FACS, FRCSC, FSSO, CME Committee Reviewer, has disclosed the following financial relationships - Checkmate Pharmaceuticals, Regeneron Pharmaceuticals, Optimum Therapeutics, Angiodynamics.

Patti Stella, CAE, CHCP, Society of Surgical Oncology, has disclosed the following financial relationships - Horizon Therapeutics, SODR Biotech (XBI).

Meagan Gilliland-Johnson, Society of Surgical Oncology, has disclosed no financial relationships.

Devin Winkler, Society of Surgical Oncology, has disclosed no financial relationships.


The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.

Disclosure of unlabeled Use

This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.

Privacy and Confidentiality

For information about the Society of Surgical Oncology’s privacy policy and associated disclaimer, please visit this site: .

System Requirements

System requirements for this activity can be found by clicking the Help button. For technical support, please contact us at

Availability: No future session
Expires on Apr 11, 2025
Cost: FREE
Credit Offered:
1 CME Credit
1 Participation Credit
Powered By